Aspirin reduces acute lung injury in rats subjected to severe hemorrhage

Tuberculosis and Respiratory Diseases

Volumn 54, Issue 5, 2003, Pages 522-531

  Shin, Tae Rim ^a   Lee, Dong Uk ^a   Park, Yoon Yub ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

Acute lung injury; Aspirin; Cyclooxygenase; Hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOPROPHYLAXIS; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMORAL ARTERY; HEMORRHAGIC SHOCK; LEUKOCYTE COUNT; LUNG INJURY; LUNG LAVAGE; MEAN ARTERIAL PRESSURE; MULTICHANNEL RECORDER; NONHUMAN; PROTEIN CONTENT; RAT;

EID: 0038166243     PISSN: 03780066     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2003.54.5.522     Document Type: Article

References (46)

1. Connelly KG, Repine JE. Markers for predicting the development of acute respiratory distress syndrome. Annu Rev Med 1997;48:429-45.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49.
3. Brigham KL, Meyrick B. Interaction of granulocytes with the lungs. Circ Res 1984;54:623-35.
4. Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983;128:552-9.
5. Gadek JE. Adverse effects of neutrophils on the lung. Am J Med 1992;92:27S-31S.
6. Fantone JC, Ward PA. Role of oxygenderived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982;107:395-418.
7. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-7,
8. Seeger W, Wolf H, Stahler G, Neuhof H, Roka L. Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs. Prostaglandins 1982;23:157-73.
9. Tate RM, Morris HG, Schroeder WR, Repine JE. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J Clin Invest 1984;74:608-13.
10. McDonald RJ, Berger EM, Repine JE. Neutrophil-derived oxygen metabolites stimulate thromboxane release, pulmonary artery pressure increases, and weight gains in isolated perfused rat lungs. Am Rev Respir Dis 1987;135:957-9.
11. Heffner JE, Sahn SA. Salicylate-induced pulmonary edema. Clinical features and prognosis. Ann Intern Med 1981;95:405-9.
12. Suarez M, Krieger BP. Bronchoalveolar lavage in recurrent aspirin-induced adult respiratory distress syndrome. Chest 1986;90:452-3.
13. Atkinson DC, Collier HO. Salicylates: molecular mechanism of therapeutic action. Adv Pharmacol Chemother 1980;17:233-88.
14. 2-Cl-system of neutrophils by indomethacin and other nonsteroidal anti-inflammatory drugs. Biochem Pharmacol 1991;41:975-84.
15. Haynes DR, Wright PF, Gadd SJ, White-house MW, Vernon-Roberts B. Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites? Agents Actions 1993;39:49-58.
16. Sagone AL, Husney RM. Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems. J Immunol 1987;138:2177-83.
17. Woollard AC, Wolff SP, Bascal ZA. Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract. Free Radic Biol Med 1990;9:299-305.
18. Carpenter-Deyo L, Roth RA. Cyclooxygenase inhibition in lungs or in neutrophils attenuates neutrophil-dependent edema in rat lungs perfused with phorbol myristate acetate. J Pharmacol Exp Ther 1989;251:983-91.
19. Zanaboni PB, Bradley JD, Baudendistel LJ, Webster RO, Dahms TE. Cyclooxygenase inhibition prevents PMA-induced increases in lung vascular permeability. J Appl Physiol 1990;69:1494-501.
20. Wahn H, Hammerschmidt S. Inhibition of PMN- and HOCl-induced vascular injury in isolated rabbit lungs by acetylsalicylic acid: a possible link between neutrophil-derived oxidative stress and eicosanoid metabolism? Biochim Biophys Acta 1998;1408:55-66.
21. Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of leukostasis in rabbit. J Appl Physiol 1991;59:1978-85.
22. Brown RE, Jarvis KL, Hyland KJ. Protein measurement using bicinchoninic acid: elimination of interfering substance. Anal Bio chem 1989;180:136-9.
23. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992;339:466-9.
24. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for the development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:293-301.
25. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998;187:917-28.
26. McCord JM. Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 1985;312:159-63.
27. Lewis JF, Ikegami M, Jobe AH. Altered surfactant function and metabolism in rabbits with acute lung injury. J Appl Physiol 1990;69:2303-10.
28. Willoughby DA, Moore AR, Colville-Nash PR, Gilroy D. Resolution of inflammation. Int J Immunopharmacol 2000;22:1131-5.
29. Awtry EH, Loscalzo J. Aspirin. Circulation 2000;101:1206-18.
30. Lopez-Farre A, Caramelo C, Esteban A, Alberola ML, Millas I, Monton M, Casado S. Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 1995;91:2080-8.
31. van Jaarsveld H, Kuyl JM, van Zyl GF, Barnard HC. Salicylate in the perfusate during ischemia/reperfusion prevented mitochondrial injury. Res Commun Mol Pathol Pharmacol 1994;86:287-95.
32. Wu KK. Biochemical pharmacology of nonsteroidal anti-inflammatory drugs. Biochem Pharmacol 1998;55:543-7.
33. Xu XM, Sansores-Garcia L, Chen XM, Matijevic-Aleksic N, Du M, Wu KK. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci USA 1999;96:5292-7.
34. Podhaisky HP, Abate A, Polte T, Oberle S, Schroder H. Aspirin protects endothelial cells from oxidative stress-possible synergism with vitamin E. FEBS Lett 1997;417:349-51.
35. Wahn H, Hammerschmidt S. Influence of cyclooxygenase and lipoxygenase inhibitors on oxidative stress-induced lung injury. Crit Care Med 2001;29:802-7.
36. Sigurdsson GH, Vallgren S, Christenson JT. Influence of aspirin and steroids on acute lung injury after i.v. injection of a sclerosing agent. Acta Chir Scand 1989;155:163-70.
37. Egan TM, Saunders NR, Dubois P, Choiniere L, McDonald JW, Cooper JD. Contribution of circulating formed elements to prostanoid production in complement-mediated lung injury in sheep. Surgery 1985;98:350-8.
38. Gilroy DW, Tomlinson A, Willoughby DA. Differential effects of inhibitors of cyclooxygenase(cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. Eur J Pharmacol 1998;355:211-7.
39. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have antiinflammatory properties. Nat Med 1999;5:698-701.
40. Beekhuizen H, van Furth R. Monocyte adherence to human vascular endothelium. J Leukoc Biol 1993;54:363-78.
41. Asako H, Kubes P, Wallace J, Wolf RE, Granger DN. Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology 1992;103:146-52.
42. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994;265:956-59.
43. Weber C, Erl W, Pietsch A, Weber PC. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 1995;91:1914-7.
44. Pillinger MH, Capodici C, Rosenthal P, Kheterpal N, Hanft S, Philips MR, Weissmann G. Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci USA 1998;95:14540-5.
45. Patrono C. Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back. Trends Pharmacol Sci 1989;10:453-8.